Nuvectis Pharma, Inc. (NVCT) Misses Q2 EPS by 5c

Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q2 EPS of ($0.30), $0.05 worse than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Jiayin Group (JFIN) Reports Q2 Loss of RMB3.56
• Donaldson Company (DCI) PT Raised to $95 at Stifel